Startups
Edvince
Edit

Edvince

http://www.edvince.com/
Last activity: -
Active
Categories: BioTechBusinessDevelopmentDrugGrowthLifeManagementResearchScienceUniversity
Edvince is a biotech company that develops a new treatment for the management of delayed cerebral ischemic events. This treatment aims to prevent the chain of events leading to brain damage subsequent to a bleed in the brain. The company is currently in the preclinical phase and will initiate its first clinical phase I study in early 2018. Edvince is based at SmiLe Incubator in Lund and is owned by its Lars Edvinsson (founder), Krankajen Group AB, LMK Forward AB, Almi Invest Syd AB, Swedish Growth Fund and Sarah Fredriksson. The business concept is based on Professor Lars Edvinsson’s many years of research at Lund University investigating what happens in the blood vessels of the brain after a bleeding, leading to delayed cerebral ischemia. The result is the discovery of a novel first-in-class treatment, with great potential to minimize brain damage.

Overview

Employees
1-10
Founded date
2003

Investors 1

DateNameWebsite
Sign up to seeSign up to seeSign up to see

Reviews 0

Sign up to leave a review

Sign up Log In

FAQ about Edvince

When was Edvince founded?

Edvince was founded in 2003.

Is Edvince still active?

Yes, Edvince is active.